These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
639 related items for PubMed ID: 31845587
1. Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial. Kang MG, Qian H, Keramatian K, Chakrabarty T, Saraf G, Lam RW, Wong H, Yatham LN. Aust N Z J Psychiatry; 2020 Mar; 54(3):298-307. PubMed ID: 31845587 [Abstract] [Full Text] [Related]
2. [Antipsychotics in bipolar disorders]. Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L. Encephale; 2004 Mar; 30(5):417-24. PubMed ID: 15627046 [Abstract] [Full Text] [Related]
3. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cipriani A, Reid K, Young AH, Macritchie K, Geddes J. Cochrane Database Syst Rev; 2013 Oct 17; 2013(10):CD003196. PubMed ID: 24132760 [Abstract] [Full Text] [Related]
4. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics. Woo YS, Bahk WM, Jung YE, Jeong JH, Lee HB, Won SH, Lee KH, Jon DI, Yoon BH, Kim MD, Min KJ. Psychiatry Clin Neurosci; 2014 Jun 17; 68(6):418-24. PubMed ID: 24506520 [Abstract] [Full Text] [Related]
5. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. Vieta E, T'joen C, McQuade RD, Carson WH, Marcus RN, Sanchez R, Owen R, Nameche L. Am J Psychiatry; 2008 Oct 17; 165(10):1316-25. PubMed ID: 18381903 [Abstract] [Full Text] [Related]
6. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Loebel A, Cucchiaro J, Silva R, Kroger H, Sarma K, Xu J, Calabrese JR. Am J Psychiatry; 2014 Feb 17; 171(2):169-77. PubMed ID: 24170221 [Abstract] [Full Text] [Related]
7. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder. Calabrese JR, Pikalov A, Streicher C, Cucchiaro J, Mao Y, Loebel A. Eur Neuropsychopharmacol; 2017 Sep 17; 27(9):865-876. PubMed ID: 28689688 [Abstract] [Full Text] [Related]
8. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Marcus R, Khan A, Rollin L, Morris B, Timko K, Carson W, Sanchez R. Bipolar Disord; 2011 Mar 17; 13(2):133-44. PubMed ID: 21443567 [Abstract] [Full Text] [Related]
9. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study. Berwaerts J, Lane R, Nuamah IF, Lim P, Remmerie B, Hough DW. J Affect Disord; 2011 Mar 17; 129(1-3):252-60. PubMed ID: 20947174 [Abstract] [Full Text] [Related]
10. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN. Curr Med Res Opin; 2010 Jun 17; 26(6):1485-96. PubMed ID: 20429835 [Abstract] [Full Text] [Related]
11. Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania. Yatham LN, Binder C, Kusumakar V, Riccardelli R. Int Clin Psychopharmacol; 2004 Mar 17; 19(2):103-9. PubMed ID: 15076019 [Abstract] [Full Text] [Related]
14. Antipsychotic adjunctive therapy to mood stabilizers and 1-year rehospitalization rates in bipolar disorder: A cohort study. Hochman E, Krivoy A, Schaffer A, Weizman A, Valevski A. Bipolar Disord; 2016 Dec 17; 18(8):684-691. PubMed ID: 27933713 [Abstract] [Full Text] [Related]
15. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N. Health Technol Assess; 2007 Oct 17; 11(39):iii-iv, ix-206. PubMed ID: 17903393 [Abstract] [Full Text] [Related]
16. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR. Br J Psychiatry; 2004 Apr 17; 184():337-45. PubMed ID: 15056579 [Abstract] [Full Text] [Related]
17. Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode. Yatham LN, Fountoulakis KN, Rahman Z, Ammerman D, Fyans P, Marler SV, Baker RA, Carlson BX. J Affect Disord; 2013 May 17; 147(1-3):365-72. PubMed ID: 23290791 [Abstract] [Full Text] [Related]
18. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. Br J Psychiatry; 2003 Feb 17; 182():141-7. PubMed ID: 12562742 [Abstract] [Full Text] [Related]
19. Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode: A Post Hoc Analysis of 2 Placebo-Controlled Trials. Tocco M, Mao Y. J Clin Psychopharmacol; 2003 Feb 17; 44(4):345-352. PubMed ID: 38639433 [Abstract] [Full Text] [Related]